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Molecular oxygen (O2) is a critical substrate for numerous biochemical reactions (e.g., the introduction of carbon double bonds into fatty acids), mitochondrial energy production, 
and the growing number of -ketoglutarate (2-oxoglutarate)-dependent oxygenases that maintain O2 homeostasis, promote collagen maturation, and impact the methylation 
status of both DNA and histones. Oxygen availability also regulates fl ux through important nutrient- and energy-sensing pathways, including mTOR, AMPK, and autophagy, as 
well as the unfolded protein response (UPR), which combats proteotoxicity. In many ways, the ongoing study of cellular, tissue, and organismal adaptations to O2 limitation, or 
“hypoxia,” in physiology and disease has numerous open-ended questions: How many of the O2/-ketoglutarate-consuming oxygenases exhibit enzymatic activity frequently 
modulated by the dynamic range of O2 concentrations typically found in healthy and/or diseased tissues? What is the scope of crosstalk between O2 levels/metabolite pools 
and durable changes in the epigenome? How is O2 sensing integrated with other environmentally regulated processes, such as circadian rhythms, neuronal activity, and zeno-
biotic metabolism? How do mTORC1 or the UPR “sense” acute decreases in O2 levels? How is the protein synthesis machinery affected by O2 availability? What is the scope of 
metabolite (lactate, 2-hydroxyglutarate) infl uences on HIF-independent hypoxic responses (Lee et al., 2015)?
These and other fundamental questions will undoubtedly continue to fascinate researchers in the hypoxia fi eld for years to come. Nevertheless, a number of recent papers 
have revealed unexpected inputs and functions for one of the best-characterized O2-sensing systems at this time—namely, the pVHL/PHD/HIF pathway. This pathway 
regulates a large transcriptome promoting hypoxic adaptations by enhancing the expression of hundreds of genes involved in metabolism, proliferation, differentiation, 
infl ammation, angiogenesis, cell motility, and “stemness.” This SnapShot highlights several exciting new concepts, such as regulatory physical interactions between HIF1/
HIF2 and metabolic enzymes like PKM2 and FBP1 (Li et al., 2014; Luo et al., 2011), HIF input into T cell function (e.g., Th17 development) (Dang et al., 2011), HIF activation 
by commensal bacteria in GI antifungal responses (Fan et al., 2015), and hypoxic infl uences on adherins junction integrity. While HIF crosstalk with metabolic pathways has 
been appreciated for some time (glycolysis, mitochondrial O2 consumption, glutamine metabolism, etc.) (Lee et al., 2014), new interfaces are continually being discovered, 
such as “pexophagy” (selective peroxisome degradation to maintain lipid homeostasis) and fructolysis, where HIF regulates ketohexokinase alternative splicing (Mirtschink et 
al., 2015; Walter et al., 2014).
Recent major advances based on comprehensive ChIPseq and chromatin capture assays in multiple cell types have also contributed to our understanding of genome-
wide HIF associations with DNA and target gene selectivity. In addition, new structural insights provided by Fraydoon Rastinejad and colleagues (Wu et al., 2015) also further 
clarify conformational changes in HIF dimers on and off DNA and contrast them with other bHLH-PAS factors, i.e., CLOCK/bMAL. This report defi nes binding “pockets” for 
previously identifi ed small-molecule inhibitors of HIF1 and HIF2 at the angstrom level and raises again the possibility that HIF’s bind endogenous ligands, as ultimately 
revealed for the AhR bHLH-PAS family member. The notion that HIF directly and indirectly controls metabolite accumulation that could, in turn, provide allosteric regulation by 
post-translational modifi cations or covalent binding presents an exciting new line of investigation for the scientifi c community.
Although the pVHL/PHD/HIF axis represents the O2 sensor studied in perhaps the greatest detail (Keith et al., 2012), much remains to be discovered. Coupled with ongoing 
efforts to characterize other pathways regulated by the 70+ O2/-ketoglutarate-consuming oxygenases, intermediate metabolism, and ion channels, the community studying 
the fundamental mechanisms governing adaptations to fl uctuating O2 levels during development, physiology, and disease will certainly be e ngaged for years to come.
ABBREVIATIONS
ARNT, aryl hydrocarbon receptor nuclear translocator; bHLH, basic helix-loop-helix; CBP, cyclic AMP response element-binding protein; FIH, factor-inhibiting hif1; HIF, hypoxia-
inducible factor; HRE, hypoxia response element; PAS, Per-Arnt-Sim; PHD, prolyl hydroxylase domain; Ub, ubiquitin; VHL, Von Hippel-Lindau tumor suppressor.
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